Differential physiologic responses of α7 nicotinic acetylcholine receptors to β‐amyloid1–40 and β‐amyloid1–42
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The β‐amyloid peptides (Aβ), Aβ 1–40 and Aβ 1–42, have been implicated in Alzheimer's disease (AD) pathology. Although Aβ 1–42 is generally considered to be the pathological peptide in AD, both Aβ 1–40 and Aβ 1–42 have been used in a variety of experimental models without discrimination. Here we show that monomeric or oligomeric forms of the two Aβ peptides, when interact with the neuronal cation channel, α7 nicotinic acetylcholine receptors (α7nAChR), would result in distinct physiologic responses as measured by acetylcholine release and calcium influx experiments. While Aβ 1–42 effectively attenuated these α7nAChR‐dependent physiology to an extent that was apparently irreversible, Aβ 1–40 showed a lower inhibitory activity that could be restored upon washings with physiologic buffers or treatment with α7nAChR antagonists. Our data suggest a clear pharmacological distinction between Aβ 1–40 and Aβ 1–42. © 2003 Wiley Periodicals, Inc. J Neurobiol 55: 25–30, 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070 · cited 1×
“, 1997), it is possible that activation of the 7nAChRs in the presynaptic cholinergic terminals mediated by the released ACh in response to depolarization such as high K may further facilitate Ca dependent depolarization-exocytosis coupling process thereby increases the magnitude of neurotransmitter release (McGehee e…”
BackgroundAssembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Zhang, Y., McLaughlin, R., Goodyer, C., & LeBlanc, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110119 · Cited by 418
D'Andrea, M. R., Nagele, R. G., Wang, H., Peterson, P. A., & Lee, D. H. S. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01082.x · Cited by 390
Self-citation
Cited by
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 530
Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease
Kar, S., Slowikowski, S. P. M., Westaway, D., & Mount, H. T. J. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0442 · Cited by 364
Verdier, Y., Zarándi, M., & Penke, B. (2004) · Journal of Peptide Science · doi:10.1002/psc.573 · Cited by 262
Cortical Plasticity in Alzheimer’s Disease in Humans and Rodents
Battaglia, F., Wang, H.-Y., Ghilardi, M. F., Gashi, E., Quartarone, A., Friedman, E., & Nixon, R. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.027 · Cited by 175
Self-citationAlzheimer's disease amyloid β-protein and synaptic function
Ondrejcak, T., Klyubin, I., Hu, N.-W., Barry, A. E., Cullen, W. K., & Rowan, M. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8091-0 · Cited by 146
“Combined with the realization that mechanisms other than neurodegeneration contribute significantly to the cognitive symptoms of AD, glutamatergic transmission and plasticity of that transmission, rather than solely excito- toxicity, have become a major focus of interest.”
BackgroundCampbell, N. R., Fernandes, C. C., Halff, A. W., & Berg, D. K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0931-10.2010 · Cited by 140
“…function either directly or indirectly (Wang et al., 2000a,b; Liu et al., 2001; Pettit et al., 2001; Dougherty et al., 2003; Grassi et al., 2003; Lee and Wang, 2003; Pym et al., 2005), although it has also been reported to have 7- nAChR agonist activity at low concentrations (Dineley et…”
The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease
Wang, Z.-X., Tan, L., Liu, J., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9143-0 · Cited by 110
Small, D. H., Maksel, D., Kerr, M. L., Ng, J., Hou, X., Chu, C., Mehrani, H., Unabia, S., Azari, M. F., Loiacono, R., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04444.x · Cited by 69
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Lilja, A. M., Porras, O., Storelli, E., Nordberg, A., & Marutle, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101242 · Cited by 57
Behavioral effects of PNU-282987, an alpha7 nicotinic receptor agonist, in mice
Vicens, P., Ribes, D., Torrente, M., & Domingo, J. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.015 · Cited by 39
Beta-amyloid oligomers: recent developments
Borutaite, V., Morkuniene, R., & Valincius, G. (2011) · bmc · doi:10.1515/bmc.2011.019 · Cited by 9
“Ab oligomers were also shown to modulate a7nAChR-mediated Ca influx in brain synaptosomes (110) and neuronal cells (111) leading to activation of a7nAChR-associated kinases and rapid Tau phosphorylation (112).”
Background
Metadata
- Authors
- Lee, D. H. S., & Wang, H.
- Venue
- Journal of Neurobiology
- Publisher
- Wiley
- Published
- 2003-02-27
- Volume
- 55
- Issue
- 1
- Pages
- 25-30
- ISSN
- 0022-3034 (ISSN-L)
- 1097-4695
- OpenAlex
- W1608873419
- Cited by
- 67
- References
- 6
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.